Signaling pathways
-
BA5586 BMT-145027Summary: BMT-145027 is an orthosteric modulator and has no intrinsic agonist activity. -
BA5587 CFMTISummary: Acts on CHO cells expressing human and rat. -
BA5588 TASP0433864Summary: TASP0433864 is a selective orthosteric modifier. -
BA5589 ValigluraxSummary: Valiglurax (VU0652957) is an orally effective selective orthosteric modulator. -
BA5590 ML254Summary: ML254 is an effective enhancer. -
BA5591 VU0360172Summary: VU0360172 is a potent and selective modulator of positive receptor modification. -
BA5592 DFMTISummary: Capable of completely blocking the rmGlu1L757V glutamate reaction. -
BA5593 VU0155094Summary: VU0155094 is an orthotropic modifier. -
BA5594 ADX71743Summary: ADX71743 is a highly selective, non-competitive and blood-brain barrier-crossing metabotropic glutamate receptor 7 negative mutational modulator. -
BA5595 VU0469650Summary: VU0469650 is a potent, selective, reverse transmutation modulator of receptors that penetrate the CNS.

